• Aggressive Breast Cancer Responds to New Drug

    2 monthes ago - By Web MD

    In the clinical trial of the new drug, sacituzumab govitecan, about a third of the patients responded to treatment and the effect lasted up to eight months. The research was funded by the drug's maker.
    Read more ...

     

  • Researchers discover potential attack strategy for aggressive breast cancer

    Researchers discover potential attack strategy for aggressive breast cancer

    2 monthes ago - By UNC Healthcare

    UNC Lineberger researchers including Leslie Parise, PhD, and department of pharmacology doctoral student Alex Chung have designed a novel way to attack an aggressive breast cancer.
    Read more ...